BioSpace News Archive

Genetown

Gamida Cell Announces Pricing of Initial Public Offering

Gamida Cell Ltd., a leading cellular and immune therapeutics company, today announced the pricing of its initial public offering of 6,250,000 ordinary shares at a public offering price of $8.00 per share for aggregate gross proceeds of $50.0 million

October 26, 2018
·
2 min read
Agfa HealthCare Wins 2018 Award of Distinction From Waterloo MedTech, Ontario, Canada

Agfa HealthCare has been recognized with the 2018 Award of Distinction by Waterloo MedTech of Canada, for ongoing innovation in healthcare technology in the Waterloo Region of Ontario.

October 26, 2018
·
3 min read
Pharm Country

Lustgarten-Funded Study in Cancer Discovery Reveals Possible New Targets for Therapeutics

Pancreatic cancer has shown to have limited effective treatment strategies. Researchers in the Lustgarten Foundation Pancreatic Cancer Research Laboratory at Cold Spring Harbor Laboratory (CSHL) have made a discovery that could lead to a different, more effective kind of treatment.

October 26, 2018
·
3 min read
Biotech Bay

4th Annual Scott Baio Celebrity Charity Golf Event for Bailey Baio Angel Foundation

The Bailey Baio Angel Foundation, a 501c3 non-profit charity dedicated to providing support to the children and families affected by metabolic immune disorders, announced that it’s 4th Annual Scott Baio Celebrity Charity Golf Tournament held, Monday, October 15th

October 26, 2018
·
2 min read
Global Retinal Vein Occlusion Treatment Market 2019-2023| Strong Pipeline and Recent Drug Approvals to Boost Demand | Technavio

The global retinal vein occlusion treatment market 2019-2023 is expected to post a CAGR of more than 9% during the forecast period, according to the latest market research report by Technavio.

October 26, 2018
·
4 min read
BioMidwest

Easier, Potentially More Effective Treatment for Blinding Eye Disease Shows Promise in Clinical Trial

A new study shows that an implantable delivery system for a widely used medication to treat a blinding eye disease has enabled some patients to go 15 months in between treatments.

October 26, 2018
·
3 min read
Biotech Bay

Ardelyx Presents New Preclinical Data Demonstrating Synergy between Tenapanor and Sevelamer When Dosed in Combination for Elevated Serum Phosphorus

Ardelyx, Inc. (Nasdaq: ARDX), today announced the presentation of preclinical data suggesting therapeutic synergy of tenapanor in combination with sevelamer, the current standard-of-care phosphate binder treatment for hyperphosphatemia, or elevated serum phosphorus.

October 26, 2018
·
5 min read
Hamamatsu Photonics has newly developed the world’s smallest grating spectrometer offering high sensitivity, compact size, light weight and low cost.

Hamamatsu Photonics has recently developed their smallest grating spectrometer, the SMD series mini-spectrometer C14384MA, offering high near-infrared sensitivity, compact size, light weight and low cost.

October 26, 2018
·
1 min read
Business

BioIVT Appoints Alan Findlater as Chief Commercial Officer

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has appointed Alan Findlater to the newly-created role of chief commercial officer.

October 26, 2018
·
3 min read
Business

Cook Regentec Celebrates Opening of Indianapolis Facility, Announces Collaboration with Indiana University School of Medicine

16 Tech Innovation District, Cook Regentec innovation space serve as backdrop for local collaborations

October 26, 2018
·
5 min read